Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03329937 |
| Title | Study Evaluating the Antitumor Activity and Safety of Niraparib as Neoadjuvant Treatment |
| Recruitment | Completed |
| Gender | female |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Tesaro, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| GSK Investigational Site | Fort Myers | Florida | 33908 | United States | Details | |
| GSK Investigational Site | Tampa | Florida | 33612 | United States | Details | |
| GSK Investigational Site | Baltimore | Maryland | 21231 | United States | Details | |
| GSK Investigational Site | Boston | Massachusetts | 02114 | United States | Details | |
| GSK Investigational Site | Rochester | Minnesota | 55905 | United States | Details | |
| GSK Investigational Site | New York | New York | 10029 | United States | Details | |
| GSK Investigational Site | Nashville | Tennessee | 37203 | United States | Details |